FFA
MLAB icon

Farther Finance Advisors’s Mesa Laboratories MLAB Stock Holding History

Farther Finance Advisors’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$49.5K Sell
381
-31
-8% -$3.52K ﹤0.01% 3436
2026
Q2 		$41K Sell
412
-57
-12% -$5.74K ﹤0.01% 3400
2026
Q1 		$41.5K Buy
469
+45
+11% +$3.88K ﹤0.01% 3119
2025
Q4 		$33.3K Sell
424
-111
-21% -$8.44K ﹤0.01% 3090
2025
Q3 		$35.9K Buy
535
+532
+17,733% +$38.3K ﹤0.01% 2644
2025
Q2 		$283 Hold
3
– – ﹤0.01% 4145
2025
Q1 		$352 Hold
3
– – ﹤0.01% 3843
2024
Q4 		$396 Hold
3
– – ﹤0.01% 3490
2024
Q3 		$390 Hold
3
– – ﹤0.01% 3478
2024
Q2 		$265 Sell
3
-3
-50% -$314 ﹤0.01% 3431
2024
Q1 		$672 Buy
6
+5
+500% +$504 ﹤0.01% 2923
2023
Q4 		$105 Buy
+1
New +$97 ﹤0.01% 3296

Other funds holding MLAB

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

Farther Finance Advisors's MLAB Position: Q3 2026 in Review

Farther Finance Advisors reduced its Mesa Laboratories (MLAB) stake by 7.5% in Q3 2026, selling an estimated $3.52K and leaving 381 shares worth $49.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3436.

Farther Finance Advisors first reported a position in MLAB in Q4 2023 and has held it in 12 quarters since. 4 funds tracked by Wall St. Rank hold MLAB as of Q3 2026.

  • Farther Finance Advisors held 381 shares of Mesa Laboratories worth $49.5K as of Q3 2026.
  • Farther Finance Advisors sold 31 Mesa Laboratories shares in Q3 2026, an estimated $3.52K.
  • Mesa Laboratories made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3436 holding.
  • Farther Finance Advisors first reported a position in Mesa Laboratories in Q4 2023 and has held it in 12 quarters since.
  • 4 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.